Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 zeta Chimeric Antigen Receptor-Modified Effector CD8(+) T Cells

K. Watanabe, S. Terakura, A.C.M. Martens, T. van Meerten, S. Uchiyama, M. Imai, R. Sakemura, T. Goto, R. Hanajiri, N. Imahashi, K. Shimada, A. Tomita, H. Kiyoi, T. Nishida, T. Naoe, M. Murata

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)911-920
JournalJournal of Immunology
Volume194
Issue number3
DOIs
Publication statusPublished - 2015

Cite this

Watanabe, K., Terakura, S., Martens, A. C. M., van Meerten, T., Uchiyama, S., Imai, M., ... Murata, M. (2015). Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 zeta Chimeric Antigen Receptor-Modified Effector CD8(+) T Cells. Journal of Immunology, 194(3), 911-920. https://doi.org/10.4049/jimmunol.1402346